Identification and Characterization of PERK Activators by Phenotypic Screening and Their Effects on NRF2 Activation

Wensheng Xie(GlaxoSmithKline (United States)), Hu Li(Tianjin Medical University General Hospital), Nilesh Chitnis(Medical University of South Carolina), Alan J. Diehl(Medical University of South Carolina), Robert S. Ames(GlaxoSmithKline (United Kingdom)), William E. Wixted(GlaxoSmithKline (United Kingdom)), Yolanda Sánchez(Dartmouth College), Marie Pariollaud(Scripps Research Institute), Yan Liu(Southwest Medical University), Christina Pao(GlaxoSmithKline (United States)), Maggie Truong(GlaxoSmithKline (United States)), James A. Fornwald(GlaxoSmithKline (United Kingdom)), James F. Callahan(GlaxoSmithKline (United States)), Roberto Solari(GlaxoSmithKline (United Kingdom))
PLoS ONE
March 17, 2015
Cited by 19


Related Papers